Riastap 1 g, Polvere per soluzione iniettabile o per infusione clinical trials

FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL

This study is looking at whether giving extra fibrinogen (a clotting protein) to people who've had a stroke and a clot-busting medicine can stop serious bleeding in the brain. They want to see if it makes treatment safer and helps people recover better.